These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24429112)

  • 1. Inhaled corticosteroids in severe COPD.
    Bousquet J
    Lancet Respir Med; 2013 May; 1(3):177-8. PubMed ID: 24429112
    [No Abstract]   [Full Text] [Related]  

  • 2. Trelegy Ellipta--a three-drug inhaler for COPD.
    Med Lett Drugs Ther; 2018 May; 60(1547):86-88. PubMed ID: 29913467
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis.
    DiSantostefano RL; Li H; Hinds D; Galkin DV; Rubin DB
    Int J Chron Obstruct Pulmon Dis; 2014; 9():457-68. PubMed ID: 24855350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluticasone furoate/vilanterol (100/25; 200/25 μg) improves lung function in COPD: a randomised trial.
    Martinez FJ; Boscia J; Feldman G; Scott-Wilson C; Kilbride S; Fabbri L; Crim C; Calverley PM
    Respir Med; 2013 Apr; 107(4):550-9. PubMed ID: 23332861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Importance of inhaled corticosteroids under discussion].
    Jäger-Becker D
    MMW Fortschr Med; 2016 Jun; 158(11):75. PubMed ID: 27271423
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of inhaled corticosteroids in the management of COPD].
    Chazan R
    Pneumonol Alergol Pol; 2009; 77(2):186-91. PubMed ID: 19462354
    [No Abstract]   [Full Text] [Related]  

  • 9. Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials.
    Dransfield MT; Bourbeau J; Jones PW; Hanania NA; Mahler DA; Vestbo J; Wachtel A; Martinez FJ; Barnhart F; Sanford L; Lettis S; Crim C; Calverley PM
    Lancet Respir Med; 2013 May; 1(3):210-23. PubMed ID: 24429127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Fluticasone Furoate-Vilanterol for COPD in Clinical Practice.
    Vestbo J; Leather D; Diar Bakerly N; New J; Gibson JM; McCorkindale S; Collier S; Crawford J; Frith L; Harvey C; Svedsater H; Woodcock A;
    N Engl J Med; 2016 Sep; 375(13):1253-60. PubMed ID: 27593504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined inhaled corticosteroid and long-acting beta-2-agonist in one inhaler in the treatment of chronic obstructive pulmonary disease].
    Pedersen ST
    Ugeskr Laeger; 2005 Jun; 167(23):2504-6. PubMed ID: 16008004
    [No Abstract]   [Full Text] [Related]  

  • 12. Anoro Ellipta: an inhaled umeclidinium/vilanterol combination for COPD.
    Med Lett Drugs Ther; 2014 Apr; 56(1440):30-1. PubMed ID: 24736248
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic obstructive pulmonary disease.
    Kerstjens H; Postma D
    Clin Evid; 2002 Jun; (7):1344-57. PubMed ID: 12243121
    [No Abstract]   [Full Text] [Related]  

  • 14. ▼Relvar Ellipta for COPD.
    Drug Ther Bull; 2014 Jun; 52(6):66-9. PubMed ID: 24904005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do chronic inhaled steroids alone or in combination with a bronchodilator prolong life in chronic obstructive pulmonary disease patients?
    Sin DD; Man SF
    Curr Opin Pulm Med; 2007 Mar; 13(2):90-7. PubMed ID: 17255798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD.
    Crim C; Dransfield MT; Bourbeau J; Jones PW; Hanania NA; Mahler DA; Vestbo J; Wachtel A; Martinez FJ; Barnhart F; Lettis S; Calverley PM
    Ann Am Thorac Soc; 2015 Jan; 12(1):27-34. PubMed ID: 25490706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in chronic obstructive pulmonary disease.
    Bakerly ND; Woodcock A; New JP; Gibson JM; Wu W; Leather D; Vestbo J
    Respir Res; 2015 Sep; 16(1):101. PubMed ID: 26337978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effects of inhaled corticosteroids in chronic obstructive pulmonary disease.
    Jones PW
    Proc Am Thorac Soc; 2004; 1(3):167-70. PubMed ID: 16113430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhalational corticosteroids in COPD. THe ISOLDE Study (Inhaled Steroids in Obstructive Lung Disease in Europe)].
    Internist (Berl); 2001 Jul; 42(7):1050-2. PubMed ID: 11476049
    [No Abstract]   [Full Text] [Related]  

  • 20. Breo Ellipta: An Inhaled Fluticasone/ Vilanterol Combination for COPD.
    Med Lett Drugs Ther; 2013 Sep; 55(1424):69-71, 45-8. PubMed ID: 26839934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.